ICON is a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar and generic organisations.
We offer a full range of clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation.
Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics. We are the only full service CRO that offers the knowledge, software and systems for adaptive trials.
Read the white paper to discover why an integrated operational framework is key to efficient data management.
Webinar: 22nd September, 2017
Learn why traditional contracting may not be enough to address the needs of both payers and pharma manufacturers.